Journey Medical Corp
Journey Medical Corporation (Nasdaq: DERM) is a commercial-stage pharmaceutical company focused primarily on selling and marketing FDA-approved prescription medicines for dermatological conditions. Its products treat rosacea, acne, excessive underarm sweating, fungal skin infections, itching and superficial wounds.… From the company’s description.
Over the twelve months to Jun 30, 2026, Journey Medical Corp reported revenue of $68.18M, up 20.9% from a year earlier, and a net loss of $6.10M. Its operating margin was −4.4%, and operations used $7.49M in cash. In fiscal 2025, it reported revenue of $61.86M, up 10.2% from fiscal 2024, and a net loss of $11.43M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Journey Medical Corp does
In the company’s own words
Journey Medical Corporation (Nasdaq: DERM) is a commercial-stage pharmaceutical company focused primarily on selling and marketing FDA-approved prescription medicines for dermatological conditions. Its products treat rosacea, acne, excessive underarm sweating, fungal skin infections, itching and superficial wounds. The portfolio includes Emrosi, an oral minocycline treatment for rosacea; Qbrexza, a prescription cloth for primary axillary hyperhidrosis; Accutane and Targadox for severe acne; Amzeeq and Zilxi topical minocycline foams for acne and rosacea; and legacy brands Exelderm and Luxamend. Journey acquires or licenses product rights and commercializes products through its field sales organization; it also develops products with partners and licenses products for sale in certain international markets. It sells mainly to specialty pharmacies, independent wholesalers and distributors, which supply pharmacies, drugstore chains and managed-care customers. The company reported eight FDA-approved dermatology drugs in its marketed portfolio and had 58 full-time employees as of March 18, 2026. Its website is www.jmcderm.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Pharmaceutical Preparations
- Headquarters
- SCOTTSDALE, AZ
- Fiscal year end
- December
- CIK
- 1867066
- SIC
- 2834
Financial performance, year by year
Fiscal 2021–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Journey Medical Corp — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Journey Medical Corp’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Journey Medical Corp and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Journey Medical Corp's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Journey Medical Corp's last four quarterly filings that the numbers alone won't show?”